Bodyguards, Luxury sneakers... Broker in Court Remains Silent on Reporters' Questions
7 Articles
7 Articles
Appeared in court on the same day as Kim Seung-won's confirmation hearing... Trial ended in just 10 minutes. 4:20 PM on the 15th, Courtroom 404, Seoul Western District Court, Mapo-gu, Seoul.
Broker Yang, a key figure in the case involving allegations of soliciting approval for new drug clinical trials by Justice Minister nominee Kim Seung-won, appeared in court on the 15th. Although this was Yang's first public appearance since the allegations surfaced, he did not answer any questions regarding the allegations against nominee Kim. The court [will...] on November 1
Mr. Yang and Mr. Kang of Genencell, who were indicted on charges of soliciting approval for a COVID-19 treatment clinical trial from Justice Minister nominee Kim Seung-won, appeared in court. They are accused of soliciting the Ministry of Food and Drug Safety to expedite approval and promising 5 million won in political donations in return, and they remained silent in response to questions from the press.
Broker Yang Mo, who was involved in the “suspicion of requesting approval for a new drug clinical trial” by a candidate for Minister of Justice Kim Seung-won, appeared in public for the first time after the suspicion was raised on the 15th. Judge Sung Jun-kyu, the sole judge of Criminal 10 of the Seoul Western District Court, opened a trial date for the alleged bribery agreement between Yang and Kang Se-chan, founder of Genencell. Yang attended …
Broker and pharmaceutical company founder on trial for allegedly promising bribes to Kim Seung-won
The prosecution's sentencing recommendation for broker Mr. Yang and Genencell founder Mr. Kang, who were indicted on charges of soliciting approval for a new COVID-19 drug clinical trial from Justice Minister nominee Kim Seung-won, is scheduled for November 11.
Coverage Details
Bias Distribution
- 34% of the sources lean Left, 33% of the sources are Center, 33% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
